Pliant Therapeutics Inc (PLRX)
13.46
-0.35
(-2.53%)
USD |
NASDAQ |
May 10, 13:31
Pliant Therapeutics Price to Book Value: 1.857 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 1.905 |
| May 08, 2024 | 1.850 |
| May 07, 2024 | 1.902 |
| May 06, 2024 | 1.902 |
| May 03, 2024 | 1.928 |
| May 02, 2024 | 1.828 |
| May 01, 2024 | 1.746 |
| April 30, 2024 | 1.630 |
| April 29, 2024 | 1.668 |
| April 26, 2024 | 1.629 |
| April 25, 2024 | 1.638 |
| April 24, 2024 | 1.641 |
| April 23, 2024 | 1.727 |
| April 22, 2024 | 1.738 |
| April 19, 2024 | 1.727 |
| April 18, 2024 | 1.681 |
| April 17, 2024 | 1.774 |
| April 16, 2024 | 1.829 |
| April 15, 2024 | 1.869 |
| April 12, 2024 | 1.952 |
| April 11, 2024 | 1.996 |
| April 10, 2024 | 1.952 |
| April 09, 2024 | 2.058 |
| April 08, 2024 | 2.030 |
| April 05, 2024 | 2.021 |
| Date | Value |
|---|---|
| April 04, 2024 | 2.007 |
| April 03, 2024 | 1.990 |
| April 02, 2024 | 2.025 |
| April 01, 2024 | 2.043 |
| March 28, 2024 | 1.895 |
| March 27, 2024 | 1.851 |
| March 26, 2024 | 1.799 |
| March 25, 2024 | 1.827 |
| March 22, 2024 | 1.864 |
| March 21, 2024 | 1.928 |
| March 20, 2024 | 1.895 |
| March 19, 2024 | 1.870 |
| March 18, 2024 | 1.857 |
| March 15, 2024 | 1.932 |
| March 14, 2024 | 1.895 |
| March 13, 2024 | 1.956 |
| March 12, 2024 | 1.926 |
| March 11, 2024 | 1.848 |
| March 08, 2024 | 1.978 |
| March 07, 2024 | 1.989 |
| March 06, 2024 | 1.994 |
| March 05, 2024 | 2.063 |
| March 04, 2024 | 2.085 |
| March 01, 2024 | 2.104 |
| February 29, 2024 | 2.019 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.8554
Minimum
May 11 2022
7.982
Maximum
Sep 14 2022
3.045
Average
2.715
Median
Price to Book Value Benchmarks
| Masimo Corp | 4.673 |
| Liquidia Corp | 19.49 |
| Vor Biopharma Inc | 0.7734 |
| CEL-SCI Corp | 6.230 |
| AIM ImmunoTech Inc | 2.196 |
Price to Book Value Related Metrics
| PS Ratio | 159.96 |
| Price | 13.46 |
| Earnings Yield | -21.32% |
| Market Cap | 811.99M |